Literature DB >> 23894173

Parenteral nutrition decreases paneth cell function and intestinal bactericidal activity while increasing susceptibility to bacterial enteroinvasion.

Aaron F Heneghan1,2, Joseph F Pierre1,2, Kanokwan Tandee3, Dhanansayan Shanmuganayagam4, Xinying Wang2,5, Jess D Reed4, James L Steele3, Kenneth A Kudsk1,2.   

Abstract

INTRODUCTION: Parenteral nutrition (PN) increases the risk of infection in patients with contraindication to enteral feeding. Paneth cells produce and secrete antimicrobial products that protect the mucosa from pathogens. Their loss is associated with increased host-pathogen interactions, mucosal inflammation, and altered microbiome composition. HYPOTHESIS: We hypothesized that PN reduces Paneth cell product expression, and these changes would reduce bactericidal properties of tissue secretions following cholinergic stimulation, increase mucosal enteroinvasion, and shift the intestinal microbiome.
METHOD: Experiment 1: Male ICR mice were randomized to Chow (n = 8) or PN (n = 8). Ileum tissue was collected for Paneth cell antimicrobial expression using RT-PCR, stimulated with a cholinergic agonist degranulate Paneth cells bactericidal activity, or used to assess bacterial enteroinvasion in EVISC. Experiment 2: Mice were randomized to Chow (n = 11) or PN (n = 8) and ileum washing was collected for 16s pyrosequencing analysis.
RESULTS: Compared to Chow, PN decreased tissue expression of REGIII-g (p < 0.002), lysozyme (p < 0.002), and cryptdin-4 (p < 0.03). At the phylum level, PN decreased total Firmicutes but increased total Bacteroidetes, and Proteobacteria. Functionally, secretions from PN tissue was less bactericidal (p < 0.03) and demonstrated increased susceptibility to enteroinvasion by E coli (p < 0.02).
CONCLUSION: PN without enteral nutrition impairs innate mucosal immune function. Tissue expression of Paneth cell antimicrobial proteins decreases associated with compositional shifts to the microbiome, decreased bactericidal activity of mucosal secretions and greater susceptibility of to enteroinvasion by E coli. These changes may explain in-part the increased risk of infection in parenterally fed patients.
© 2013 American Society for Parenteral and Enteral Nutrition.

Entities:  

Keywords:  Paneth cells; innate immunity, cryptdins, microbiome; parenteral nutrition; small intestine

Mesh:

Substances:

Year:  2013        PMID: 23894173      PMCID: PMC4843109          DOI: 10.1177/0148607113497514

Source DB:  PubMed          Journal:  JPEN J Parenter Enteral Nutr        ISSN: 0148-6071            Impact factor:   4.016


  50 in total

1.  Individuality in gut microbiota composition is a complex polygenic trait shaped by multiple environmental and host genetic factors.

Authors:  Andrew K Benson; Scott A Kelly; Ryan Legge; Fangrui Ma; Soo Jen Low; Jaehyoung Kim; Min Zhang; Phaik Lyn Oh; Derrick Nehrenberg; Kunjie Hua; Stephen D Kachman; Etsuko N Moriyama; Jens Walter; Daniel A Peterson; Daniel Pomp
Journal:  Proc Natl Acad Sci U S A       Date:  2010-10-11       Impact factor: 11.205

2.  The Paneth cell and the innate immune response.

Authors:  Charles L Bevins
Journal:  Curr Opin Gastroenterol       Date:  2004-11       Impact factor: 3.287

3.  Reduced Paneth cell alpha-defensins in ileal Crohn's disease.

Authors:  Jan Wehkamp; Nita H Salzman; Edith Porter; Sabine Nuding; Michael Weichenthal; Robert E Petras; Bo Shen; Elke Schaeffeler; Matthias Schwab; Rose Linzmeier; Ryan W Feathers; Hiutung Chu; Heriberto Lima; Klaus Fellermann; Tomas Ganz; Eduard F Stange; Charles L Bevins
Journal:  Proc Natl Acad Sci U S A       Date:  2005-12-05       Impact factor: 11.205

Review 4.  Paneth cells, defensins, and the commensal microbiota: a hypothesis on intimate interplay at the intestinal mucosa.

Authors:  Nita H Salzman; Mark A Underwood; Charles L Bevins
Journal:  Semin Immunol       Date:  2007-05-07       Impact factor: 11.130

5.  Muc2-deficient mice spontaneously develop colitis, indicating that MUC2 is critical for colonic protection.

Authors:  Maria Van der Sluis; Barbara A E De Koning; Adrianus C J M De Bruijn; Anna Velcich; Jules P P Meijerink; Johannes B Van Goudoever; Hans A Büller; Jan Dekker; Isabelle Van Seuningen; Ingrid B Renes; Alexandra W C Einerhand
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

6.  Protection by group II phospholipase A2 against Staphylococcus aureus.

Authors:  V J Laine; D S Grass; T J Nevalainen
Journal:  J Immunol       Date:  1999-06-15       Impact factor: 5.422

7.  Route of nutrition influences intercellular adhesion molecule-1 expression and neutrophil accumulation in intestine.

Authors:  K Fukatsu; A H Lundberg; M K Hanna; Y Wu; H G Wilcox; D N Granger; A O Gaber; K A Kudsk
Journal:  Arch Surg       Date:  1999-10

8.  Parenteral nutrition suppresses the bactericidal response of the small intestine.

Authors:  Jiro Omata; Joseph F Pierre; Aaron F Heneghan; Francis H C Tsao; Yoshifumi Sano; Mark A Jonker; Kenneth A Kudsk
Journal:  Surgery       Date:  2012-06-13       Impact factor: 3.982

Review 9.  Microbiology and management of abdominal infections.

Authors:  Itzhak Brook
Journal:  Dig Dis Sci       Date:  2008-02-21       Impact factor: 3.199

Review 10.  Paneth cell defensins: endogenous peptide components of intestinal host defense.

Authors:  A J Ouellette; M E Selsted
Journal:  FASEB J       Date:  1996-09       Impact factor: 5.191

View more
  24 in total

Review 1.  The gastrointestinal immune system: Implications for the surgical patient.

Authors:  Joseph F Pierre; Rebecca A Busch; Kenneth A Kudsk
Journal:  Curr Probl Surg       Date:  2015-10-23       Impact factor: 1.909

2.  Bombesin Preserves Goblet Cell Resistin-Like Molecule β During Parenteral Nutrition but Not Other Goblet Cell Products.

Authors:  Rebecca A Busch; Aaron F Heneghan; Joseph F Pierre; Joshua C Neuman; Claire A Reimer; Xinying Wang; Michelle E Kimple; Kenneth A Kudsk
Journal:  JPEN J Parenter Enteral Nutr       Date:  2015-05-01       Impact factor: 4.016

Review 3.  Intestine, immunity, and parenteral nutrition in an era of preferred enteral feeding.

Authors:  Meredith Barrett; Farokh R Demehri; Daniel H Teitelbaum
Journal:  Curr Opin Clin Nutr Metab Care       Date:  2015-09       Impact factor: 4.294

4.  Cysteinyl-glycine reduces mucosal proinflammatory cytokine response to fMLP in a parenterally-fed piglet model.

Authors:  Matthew G Nosworthy; Janet A Brunton
Journal:  Pediatr Res       Date:  2016-04-07       Impact factor: 3.756

Review 5.  Gastrointestinal immune and microbiome changes during parenteral nutrition.

Authors:  Joseph F Pierre
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-02-02       Impact factor: 4.052

6.  Bacterial nutrient foraging in a mouse model of enteral nutrient deprivation: insight into the gut origin of sepsis.

Authors:  Matthew W Ralls; Farokh R Demehri; Yongjia Feng; Sasha Raskind; Chunhai Ruan; Arno Schintlmeister; Alexander Loy; Buck Hanson; David Berry; Charles F Burant; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-09-01       Impact factor: 4.052

7.  The enteric nervous system neuropeptide, bombesin, reverses innate immune impairments during parenteral nutrition.

Authors:  Rebecca A Busch; Aaron F Heneghan; Joseph F Pierre; Xinying Wang; Kenneth A Kudsk
Journal:  Ann Surg       Date:  2014-09       Impact factor: 12.969

8.  Intestinal Microbiota, Lipids, and the Pathogenesis of Intestinal Failure-Associated Liver Disease.

Authors:  Way Seah Lee; Ronald J Sokol
Journal:  J Pediatr       Date:  2015-06-27       Impact factor: 4.406

Review 9.  Hypermetabolism and Nutritional Support in Sepsis.

Authors:  John C Alverdy
Journal:  Surg Infect (Larchmt)       Date:  2018-02-02       Impact factor: 2.150

10.  Homeostasis alteration within small intestinal mucosa after acute enteral refeeding in total parenteral nutrition mouse model.

Authors:  Yongjia Feng; Meredith Barrett; Yue Hou; Hong Keun Yoon; Takanori Ochi; Daniel H Teitelbaum
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2015-12-03       Impact factor: 4.052

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.